Increasingly prevalent acute and chronic human brain diseases are scourges for the elderly.
Besides the lack of therapies, these ailments share a neuroinflammation that is …

Due to the fast global spreading of the Severe Acute Respiratory Syndrome Coronavirus–2
(SARS-CoV-2), prevention and treatment options are direly needed in order to control …

Ever since it was first reported in Wuhan, China, the coronavirus-induced disease of 2019
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …

In late 2021, the US Centers for Disease Control and Prevention (CDC) posted an interim
final rule (86 FR 64075) to the federal register regulating the possession, use, and transfer of …

Increasing evidence supports the pathogenic role of neuroinflammation in psychiatric
diseases, including major depressive disorder (MDD) and neuropsychiatric symptoms of …

Recent research on placental, embryo, and brain organoids suggests that the COVID-19
virus may potentially affect embryonic organs, including the brain. Given the established link …

Since the outbreak of coronavirus disease 2019 (COVID‐19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, global public health and the …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative
pathogen of the coronavirus disease 2019 (COVID-19) pandemic, a fatal respiratory illness …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is responsible for 267 million
infections and over 5 million deaths globally. COVID-19 is caused by severe acute …

Nimbolide, a limonoid compound found in the neem plant, was investigated for effects on
neuroinflammation in BV-2 microglia activated with lipopolysaccharide (LPS). Cultured BV-2 …